@phdthesis{Laisney2010, author = {Laisney, Juliette Agn{\`e}s Genevi{\`e}ve Claire}, title = {Characterisation and regulation of the Egfr/Egfr ligand system in fish models for melanoma}, url = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-51369}, school = {Universit{\"a}t W{\"u}rzburg}, year = {2010}, abstract = {Fish of the genus Xiphophorus belong to the oldest animal models in cancer research. The oncogene responsible for the generation of spontaneous aggressive melanoma encodes for a mutated epidermal growth factor receptor (Egfr) and is called xmrk for Xiphophorus melanoma receptor kinase. Xmrk constitutive activation mechanisms and subsequent signaling pathways have already been investigated and charaterized but it is still unknown if Egfr ligands may also play a role in Xmrk-driven melanoma formation. To investigate the potential role of Egfr ligands in Xmrk-driven melanoma, I firstly analyzed the evolution of teleost and tetrapod Egfr/Egfr ligand systems. I especially focused on the analysis on the medaka fish, a closely related species to Xiphophorus, for which the whole genome has been sequenced. I could identify all seven Egfr ligands in medaka and could show that the two teleost-specific Egfr copies of medaka display dissimilar expression patterns in adult tissues together with differential expression of Egfr ligand subsets, arguing for subfunctionalization of receptor functions in this fish. Our phylogenetic and synteny analyses supported the hypothesis that only one gene in the chordate ancestor gave rise to the diversity of Egfr ligands found in vertebrate genomes today. I also could show that the Egfr extracellular subdomains implicated in ligand binding are not evolutionary conserved between tetrapods and teleosts, making the use of heterologous ligands in experiments with fish cells debatable. Despite its well understood and straight-forward process, Xmrk-driven melanomagenesis in Xiphophorus is problematic to further investigate in vivo. Our laboratory recently established a new melanoma animal model by generating transgenic mitf::xmrk medaka fishes, a Xiphophorus closely related species offering many more advantages. These fishes express xmrk under the control of the pigment-cell specific Mitf promoter. During my PhD thesis, I participated in the molecular analysis of the stably transgenic medaka and could show that the Xmrk-induced signaling pathways are similar when comparing Xiphophorus with transgenic mitf::xmrk medaka. These data together with additional RNA expression, protein, and histology analyses showed that Xmrk expression under the control of a pigment cell-specific promoter is sufficient to induce melanoma in the transgenic medaka, which develop very stereotyped tumors, including uveal and extracutaneous melanoma, with early onset during larval stages. To further investigate the potential role of Egfr ligands in Xmrk-driven melanoma, I made use of two model systems. One of them was the above mentioned mitf::xmrk medaka, the other was an in-vitro cell culture system, where the EGF-inducible Xmrk chimera HERmrk is stably expressed in murine melanocytes. Here I could show that HERmrk activation strongly induced expression of amphiregulin (Areg) and heparin-binding EGF-like growth factor (Hbegf) in melanocytes. This regulation was dependent on the MAPK and SRC signaling pathways. Moreover, upregulation of Adam10 and Adam17, the two major sheddases of Egfr ligands, was observed. I also could demonstrate the functionality of the growth factors by invitro analyses. Using the mitf::xmrk medaka model I could also show the upregulation of a subset of ligand genes, namely egf, areg, betacellulin (btc) and epigen (epgn) as well as upregulation of medaka egfrb in tumors from fish with metastatic melanoma. All these results converge to support an Xmrk-induced autocrine Egfr ligand loop. Interestingly, my in-vitro experiments with conditioned supernatant from medaka Egf- and Hbegf-producing cells revealed that not only Xiphophorus Egfrb, but also the pre-activated Xmrk could be further stimulated by the ligands. Altogether, I could show with in-vitro and in-vivo experiments that Xmrk is capable of inducing a functional autocrine Egfr ligand loop. These data confirm the importance of autocrine loops in receptor tyrosine kinase (RTK)-dependent cancer development and show the possibility for a constitutively active RTK to strengthen its oncogenic signaling by ligand binding.}, subject = {Schwertk{\"a}rpfling}, language = {en} } @phdthesis{Schaafhausen2014, author = {Schaafhausen, Maximilian}, title = {Development of a fish melanoma angiogenesis model}, url = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-101043}, school = {Universit{\"a}t W{\"u}rzburg}, year = {2014}, abstract = {Malignant melanoma is the most severe form of all skin cancers with a particular poor prognosis once metastases have developed. Angiogenesis, the formation of new blood vessels, is a prominent feature of human melanoma, which have angiogenic activity already early in development. This is at least partly ascribed to the action of MAPK- and PI3K pathways which are hyperactivated in most melanoma. Animal models which combine in depth in vivo examinations with the opportunity to perform small molecular screens are well suited to gain a more detailed insight into how this type of cancer modulates its angiogenic program. Here, a first transgenic melanoma angiogenesis model was established in the fish species Oryzias latipes (Japanese medaka). In this model, tumors are generated by the pigment cell-specific expression of the oncogenic receptor tyrosine kinase Xmrk. Xmrk is a mutated version of the fish Egfp. Furthermore, to get an angiogenesis model, a medaka line with endothelial cell specific GFP expression was used. By using crosses between these Xmrk- and GFP transgenic fishes, it was shown that angiogenesis occurs in a reactive oxygen species- and NF-κB-dependent manner, but was hypoxia-independent. It was observed that blood vessel sprouting and branch point formation was elevated in this model and furthermore that sprouting could even be induced by single transformed cells. The mouse melanocytes expressing the oncogenic receptor tyrosine kinase Xmrk as well human melanoma cells, which display various oncogenic alterations, produced pro-angiogenic factors, most prominently angiogenin, via NF-κB signaling. Furthermore, inhibiting NF-κB action prevented tumor angiogenesis and even led to the regression of existing tumor blood vessels. In summary, the present medaka melanoma angiogenesis model displays a high sensitivity for angiogenesis detection and is perfectly suited as in vivo model for the testing of anti-angiogenesis inhibitors, as exemplified by the NF-kappaB inhibitor. Furthermore, results indicate that it might be a promising anti-tumor strategy to target signaling pathways such as the NF-κB pathway which are able to induce angiogenesis-dependent as well as -independent pro-tumorigenic effects.}, subject = {Melanom}, language = {en} }